CoChat

Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review

Open access
Kaida, K., Ariga, T., Yu, R. K · 2009 · Glycobiology

The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.

Abstract

Guillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy which can cause acute quadriplegia. Infection with micro-organisms, including Campylobacter jejuni (C. jejuni), Haemophilus influenzae, and Cytomegalovirus (CMV), is recognized as a main triggering event for the disease. Lipooligosaccharide (LOS) genes are responsible for the formation of human ganglioside-like LOS structures in infectious micro-organisms that can induce GBS. Molecular mimicry of LOSs on the surface of infectious agents and of ganglioside antigens on neural cells is thought to induce cross-reactive humoral and cellular immune responses. Patients with GBS develop antibodies against those gangliosides, resulting in autoimmune targeting of peripheral nerve sites, leading to neural damage. Heterogeneity of ganglioside expression in the peripheral nervous system (PNS) may underlie the differential clinical manifestation of the GBS variants. Recent studies demonstrate that some GBS sera react with ganglioside complexes consisting of two different gangliosides, such as GD1a and GD1b, or GM1 and GD1a, but not with each constituent ganglioside alone. The discovery of antiganglioside complex antibodies not only improves the detection rate of autoantibodies in GBS, but also provides a new concept in the antibody-antigen interaction through clustered carbohydrate epitopes. Although ganglioside mimicry is one of the possible etiological causes of GBS, unidentified factors may also contribute to the pathogenesis of GBS. While GBS is not considered a genetic disease, host factors, particularly human lymphocyte antigen type, appear to have a role in the pathogenesis of GBS following C. jejuni infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/glycob/cwp027

Cites

226 of 226 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 226 references

Research works printed but not linked: 10

  1. Bullens, 2002, Journal of Neuroscience, 22, 6876
  2. 2005, 22, 763
  3. 1998, 222, 177
  4. Kusunoki, 1999, Annals of neurology, 45, 400, 10.1002/1531-8249(199903)45:3<400::AID-ANA19>3.0.CO;2-Y · doi:10.1002/1531-8249(199903)45:3<400::aid-ana19>3.0.co;2-y
  5. Kusunoki, 1997, Muscle & nerve, 20, 840, 10.1002/(SICI)1097-4598(199707)20:7<840::AID-MUS8>3.0.CO;2-7 · doi:10.1002/(sici)1097-4598(199707)20:7<840::aid-mus8>3.0.co;2-7
  6. Ogawara, 2000, Annals of neurology, 48, 624, 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O · doi:10.1002/1531-8249(200010)48:4<624::aid-ana9>3.0.co;2-o · Paper page
  7. Reuben, 2003, Neurology India, 51, 487
  8. Ropper, 1986, Archives of Neurology, 43, 1150, 10.1001/archneur.43.11.1150 · doi:10.1001/archneur.43.11.1150
  9. 2004, The Journal of Lipid Research, 45, 783, 10.1194/jlr.R300020-JLR200 · doi:10.1194/jlr.r300020-jlr200 · Paper page
  10. Yuki, 2000, Annals of neurology, 47, 314, 10.1002/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C · doi:10.1002/1531-8249(200003)47:3<314::aid-ana6>3.0.co;2-c

Cited by

Metadata

Authors
Kaida, K., Ariga, T., & Yu, R. K.
Affiliations
Augusta University (US)
Venue
Glycobiology
Published
2009-02-24
Volume
19
Issue
7
Pages
676-692
ISSN
  • 0959-6658 (ISSN-L)
  • 1460-2423
OpenAlex
W2097643820
Cited by
155
References
226
Citations by year
2026: 4 · 2025: 11 · 2024: 3 · 2023: 11 · 2022: 14 · 2021: 9 · 2020: 16 · 2019: 11 · 2018: 4 · 2017: 4 · 2016: 9 · 2015: 5 · 2014: 8 · 2013: 4 · 2012: 10
FWCI
1.57
Type
journal article
Language
en
Open access
Locations
  • Glycobiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS011853, R01NS026994, NS26994, NS-11 853)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
Keywords
Guillain-Barré syndrome, anti-ganglioside antibodies, gangliosides, lipooligosaccharide, molecular mimicry, Campylobacter jejuni, autoantibodies, GD1a, GM1, HLA, polyradiculoneuropathy, pathogenesis, infection-triggered autoimmunity
MeSH terms
Animals, Antigen-Antibody Reactions, Autoantibodies, Gangliosides, Humans, Lipopolysaccharides, Molecular Mimicry, Guillain-Barre Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.